Form 4: American Oncology Network Director William Valle Receives Stock Grant

Director William Valle received 14,981 shares of Class A Common Stock from American Oncology Network, Inc. for his service on the Board of Directors.

Summary

• William Valle, a director of American Oncology Network, Inc. (AONC), received 14,981 shares of Class A Common Stock on May 4, 2024.
• The shares were granted for his service as an independent director on the company's Board of Directors.
• These shares will vest on May 4, 2025.
• The transaction was reported on May 7, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate governance practice of compensating board members with stock, which is generally viewed positively as it aligns interests. There are no indications of negative news or concerns.

Positives

• The stock grant aligns the director's interests with those of the shareholders.
• The vesting period of one year encourages continued service on the board.

Industry Context

Stock grants to board members are a common practice in corporate governance to incentivize and align their interests with the company's long-term success.

Stakeholder Impact

• The stock grant could have a slightly dilutive effect on existing shareholders.
• The grant incentivizes the director to act in the best interests of the company, which benefits shareholders.

Key Dates

Keywords

Form 4, AONC, American Oncology Network, Director Compensation, Stock Grant, William Valle, Beneficial Ownership